Early Identification of Patients Who Benefit From Palbociclib in Addition to Letrozole
Latest Information Update: 04 Nov 2022
At a glance
- Drugs Palbociclib (Primary) ; Letrozole
- Indications Advanced breast cancer; HER2 negative breast cancer
- Focus Therapeutic Use
- 11 Oct 2022 Status changed from active, no longer recruiting to completed.
- 08 Jun 2020 Planned End Date changed from 1 May 2020 to 1 May 2022.
- 08 Jun 2020 Planned primary completion date changed from 1 May 2020 to 1 May 2022.